Abstract
Although the category “race” fails as a postulated natural kind, racial, ethnic, national, linguistic, religious, and other group designations might nonetheless be considered projectible insofar as they support inductive inferences in biomedicine. This article investigates what it might mean for group concepts in population genetics and genomics to be projectible and whether the projectibility of such predicates licenses the representation of their corresponding classes as natural kinds according to currently prevailing projectibility-based accounts of natural kinds. The article draws on a case study from cancer genetics, specifically, breast cancer risk in Ashkenazi Jewish women.
Similar content being viewed by others
Notes
These BRCA1 mutations are also referred to as 187delAG and 5385insC.
In a UK study, in contrast, 22 mutations were found in 32 of 60 families with breast and/or ovarian cancer of “predominantly British origin,” but 185delAG was only found once (Gayther et al. 1995).
Despite his empiricism and attention to practice, in FFF, Goodman appears to adhere to a dichotomy. Although he describes predicates and hypotheses as more and less projectible and entrenched, positive instances either confirm a hypothesis or they do not, and this follows from their projectibility—perhaps, for him, degrees of projectibility reflect the record’s incompleteness, not what it will eventually reveal.
However, Goodman himself (1973, p. 103), using a statistical hypothesis about shape distribution among emeralds as an example, says in a footnote that “the treatment of statistical hypotheses is a complicated matter requiring redefinition of support, violation, conflict, and so on.”
In using differences in “ascertainment strategies” to explain why their results were more similar to one US study than another, the Australian researchers assume an underlying truth about Ashkenazi Jewish mutation frequencies that ignores the heterogeneity of those who identify as Ashkenazi Jews.
References
Abbott A (2008) Europe to pay royalties for cancer gene. Nature 456:566
Anglian Breast Cancer Study Group (2000) Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br J Cancer 83:1301–1308
Anonymous (2011) Breast cancer. New York Times. http://health.nytimes.com/health/guides/disease/breast-cancer/risk-factors.html
Bahar AY, Taylor PJ, Andrews L, Proos A, Burnett L, Tucker K, Friedlander M, Buckley MF (2001) The frequency of founder mutations in the BRCA1, BRCA2, and APC genes in Australian Ashkenazi Jews: implications for the generality of US population data. Cancer 92:440–445
Beatty J (1995) The evolutionary contingency thesis. In: Wolters G, Lennox JG (eds) Concepts, theories, and rationality in the biological Sciences. Universitätsverlag, Konstanz, University of Pittsburgh Press, Pittsburgh, pp 45–81
Boyd RN (1999) Kinds, complexity and multiple realization: comments on Millikan’s “Historical kinds and the special sciences.” Philos Stud 95:67–98
Boyd R (2003) Finite beings, finite goods: the semantics, metaphysics and ethics of naturalist consequentialism, part 1. Philos Phenomenol Res 66:505–553
Brandon RN (1997) Does biology have laws? The experimental evidence. Philos Sci 64:S444–S457
Brandt-Rauf SI, Raveis VH, Drummond NF, Conte JA, Rothman SM (2006) Ashkenazi Jews and breast cancer: the consequences of linking ethnic identity to genetic disease. Am J Public Health 96:1979–1988
Carnap R (1947) On the application of inductive logic. Philos Phenomenol Res 8:133–148
Cohen T, Vardi-Saliternik R, Friedlander Y (2004) Consanguinity, intracommunity and intercommunity marriages in a population sample of Israeli Jews. Ann Human Biol 31:38–48
Fehr C, Plaisance KS (2010) Socially relevant philosophy of science: an introduction. Synthese 177:301–316
Feldman GE (2001) Do Ashkenazi Jews have a higher than expected cancer burden? Implications for cancer control prioritization efforts. Israeli Med Assoc J 3:341–346
Friedman LS, Szabo CI, Ostermeyer EA, Dowd P, Butler L, Park T, Lee MK, Goode EL, Rowell SE, King M-C (1995) Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. Am J Human Genet 57:1284–1297
Gannett L (2010) Questions asked and unasked: how by worrying less about the “really real” philosophers of science might better contribute to debates about genetics and race. Synthese 177:363–385
Gannett L (in preparation) Biogeographical ancestry and race
Gayther SA, Warren W, Mazoyer S, Russell PA, Harrington PA, Chiano M, Seal S, Hamoudi R, van Rensburg EJ, Dunning AM, Love R, Evans G, Easton D, Clayton D, Stratton MR, Ponder BAJ (1995) Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation. Nat Genet 11:428–433
Gayther SA, Harrington P, Russell P, Kharkevich G, Garkavtseva RF, Ponder BAJ (1997) Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia. Am J Human Genet 60:1239–1242
Gold ER, Carbone J (2010) Myriad genetics: in the eye of the policy storm. Genet Med 12:S39–S70
Goodman N (1946) A query on confirmation. J Philos 43:383–385
Goodman N (1947) The problem of counterfactual conditionals. J Philos 44:113–128
Goodman N (1973) Fact, fiction, and forecast, 3rd edn. Bobbs-Merrill, Indianapolis
Goodman N (1978) Ways of worldmaking. Hackett, Indianapolis
Gould SJ (1989) Wonderful life: the Burgess Shale and the nature of history. Norton, New York
Griffiths PE (1996) Darwinism, process structuralism, and natural kinds. Philos Sci 63(Proceedings):S1–S9
Griffiths PE (1999) Squaring the circle: natural kinds with historical essences. In: Wilson RA (ed) Species: new interdisciplinary essays. MIT Press, Cambridge, pp 209–228
Griffiths PE (2004) Emotions as natural and normative kinds. Philos Sci 71:901–911
Häggqvist S (2005) Kinds, projectibility, and explanation. Croat J Philos 5(13):71–87
Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King M-C (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250:1684–1689
Hall MJ, Reid JE, Burbridge LA, Pruss D, Deffenbaugh AM, Frye C, Wenstrup RJ, Ward BE, Scholl TA, Noll WW (2009) BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer 115:2222–2233
Hamel N, Feng B-J, Foretova L, Stoppa-Lyonnet D, Narod SA, Imyanitov E, Sinilnikova O, Tihomirova L, Lubinski J, Gronwald J, Gorski B, Hansen TO, Nielsen FC, Thomassen M, Yannoukakos D, Konstantopoulou I, Zajac V, Ciernikova S, Couch FJ, Greenwood CMT, Goldgar DE, Foulkes WD (2011) On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations. Eur J Human Genet 19:300–306
Kedar-Barnes I, Rozen P (2004) The Jewish people: their ethnic history, genetic disorders and specific cancer susceptibility. Fam Cancer 3:193–199
King M-C, Marks JH, Mandell JB, New York Breast Cancer Study Group (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643–646
McPherson K, Steel CM, Dixon JM (2000) Breast cancer: epidemiology, risk factors, and genetics. Br Med J 321:624–628
Metcalfe KA, Poll A, Royer R, Llacuachaqui M, Tulman A, Sun P, Narod SA (2010) Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women. J Clin Oncol 28:387–391
Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66–71
Millikan RG (1999) Historical kinds and the “special sciences.” Philos Stud 95:45–65
Mjoseth J (2012) Researchers examine genomics for breast cancer treatment. National Human Genome Research Institute. http://www.genome.gov/27546796n
Myriad Genetic Laboratories, Inc. (2012a) Services and price list (information current as of 03/13/12)
Myriad Genetic Laboratories, Inc. (2012b) BRACAnalysis® test request form and statement of medical necessity. https://www.myriadpro.com/tools-your-practice/sample-test-request-forms
National Cancer Institute (2009) BRCA1 and BRCA2: cancer risk and genetic testing. http://www.cancer.gov/cancertopics/factsheet/Risk/BRCA
National Cancer Institute (2012) Genetics of breast and ovarian cancer. http://www.cancer.gov/cancertopics/pdq/genetics/breast-and-ovarian/HealthProfessional
Neuhausen S, Gilewski T, Norton L, Tran T, McGuire P, Swensen J, Hampel H, Borgen P, Brown K, Skolnick M, Shattuck-Eidens D, Jhanwar S, Goldgar D, Offit K (1996) Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat Genet 13:126–128
Nissan A, Spira RM, Hamburger T, Badrriyah M, Prus D, Cohen T, Hubert A, Freund HR, Peretz T (2004) Clinical profile of breast cancer in Arab and Jewish women in the Jerusalem area. Am J Surg 188:62–77
Oddoux C, Struewing JP, Clayton CM, Neuhausen S, Brody LC, Kaback M, Haas B, Norton L, Borgen P, Jhanwar S, Goldgar D, Ostrer H, Offit K (1996) The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet 14:188–190
Pollack A (2011) Despite gene patent victory, Myriad Genetics faces challenges. New York Times (24 August). http://www.nytimes.com/2011/08/25/business/despite-gene-patent-victory-myriad-genetics-faces-challenges.html
Putnam H (1975) Mind, language, and reality: philosophical papers, vol 2. Cambridge University Press, Cambridge
Roa BB, Boyd AA, Volcik K, Richards CS (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14:185–187
Rubinstein WS (2004) Hereditary breast cancer in Jews. Fam Cancer 3:249–257
Schwartz GF, Hughes KS, Fabian CJ, Fentiman IS, Robson ME, Domchek SM, Hartmann LC, Holland R, Winchester DJ, and the Consensus Conference Committee (2008) Proceedings of the International Consensus Conference on Breast Cancer Risk, Genetics, & Risk Management. Cancer 113:2627–2637
Struewing JP, Brody LC, Erdos MR, Kase RG, Giambarresi TR, Smith SA, Collins FS, Tucker MA (1995a) Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am J Human Genet 57:1–7
Struewing JP, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS, Brody LC (1995b) The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 11:198–200
Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401–1408
Szabo C, King M-C (1997) Population genetics of BRCA1 and BRCA2. Am J Human Genet 60:1013–1020
Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, Merajver S, Thorlacius S, Offit K, Stoppa-Lyonnet D, Belanger C, Bell R, Berry S, Bogden R, Chen Q, Davis T, Dumont M, Frye C, Hattier T, Jammulapati S, Janecki T, Jiang P, Kehrer R, Leblanc J-F, Mitchell JT, McArthur-Morrison J, Nguyen K, Peng Y, Samson C, Schroeder M, Snyder SC, Steele L, Stringfellow M, Stroup C, Swedlund B, Swensen J, Teng D, Thomas A, Tran T, Tran T, Tranchant M, Weaver-Feldhaus J, Wong AKC, Shizuya H, Eyfjord JE, Cannon-Albright L, Labrie F, Skolnick MH, Weber B, Kamb A, Goldgar DE (1996) The complete BRCA2 gene and mutations and chromosome 13q-linked kindreds. Nat Genet 12:333–337
Tonin P, Serova O, Lenoir G, Lynch H, Durocher F, Simard J, Morgan K, Narod S (1995) BRCA1 mutations in Ashkenazi Jewish women. Am J Human Genet 57:189
Wilkerson TE (1988) Natural kinds. Philosophy 63:29–42
Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D, Fields P, Marshall G, Narod S, Lenoir GM, Lynch H, Feunteun J, Devilee P, Cornelisse CJ, Menko FH, Daly PA, Ormiston W, McManus R, Pye C, Lewis CM, Cannon-Albright LA, Peto J, Ponder BAJ, Skolnick MH, Easton DF, Goldgar DE, Stratton MR (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12–13. Science 265:2088–2090
Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G, Barfoot R, Hamoudi R, Patel S, Rices C, Biggs P, Hashim Y, Smith A, Connor F, Arason A, Gudmundsson J, Ficenec D, Kelsell D, Ford D, Tonin P, Bishop DT, Spurr NK, Ponder BAJ, Eeles R, Peto J, Devilee P, Cornelisse C, Lynch H, Narod S, Lenoir G, Egilsson V, Barkadottir RB, Easton DF, Bentley DR, Futreal PA, Ashworth A, Stratton MR (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789–792
World Health Organization (2012) Breast cancer: prevention and control. http://www.who.int/cancer/detection/breastcancer/en/index1.html
Acknowledgments
I am grateful for the opportunity to have participated in the workshop on natural kinds that was held in September 2011 in Granada, where excellent conversations and tapas were in constant supply; thanks go to organizers, María José Frápolli, Miles MacLeod, and Thomas Reydon, and sponsors, the Konrad Lorenz Institute for Evolution and Cognition Research and the Department of Philosophy I, University of Granada. This paper was vastly improved with the help of the amazing editorial duo of Miles and Thomas, insightful audiences in Granada and at University of Bielefeld’s philosophy club meeting (especially Maria Kronfeldner, Christian Nimtz, and Yuri Pascacio Montijo), and three generous reviewers for this journal.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gannett, L. Projectibility and Group Concepts in Population Genetics and Genomics. Biol Theory 7, 130–143 (2013). https://doi.org/10.1007/s13752-012-0085-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13752-012-0085-8